Prognia
Drug Database
🇪🇺EU · EMAApplication withdrawnATC: R06AX27

Desloratadine Krka(desloratadine)

Rhinitis, Allergic, Perennial;Rhinitis, Allergic, Seasonal

Marketing Authorisation Holder: Krka, d.d., Novo mesto

INN: desloratadine

Indication

Relief of symptoms of allergic rhinitis and urticaria

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Desloratadine Krka — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.